Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$277M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$230M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$152M |
| 4 |
Philip Morris
PM
|
$62.3M |
| 5 |
Adobe
ADBE
|
$61.5M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$127M |
| 2 |
TSMC
TSM
|
$63.4M |
| 3 |
Apple
AAPL
|
$54.8M |
| 4 |
Oracle
ORCL
|
$54M |
| 5 |
Pfizer
PFE
|
$45.1M |
Sector Composition
| 1 | Technology | 26.1% |
| 2 | Communication Services | 14.36% |
| 3 | Healthcare | 13.36% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
3M
MMM
$82B
| $12.5M | 0.1% |
99,022
-6,652
| -6% | -$838K |
|
|
MON
227
DELISTED
Monsanto Co
MON
| $12.4M | 0.1% |
126,099
-1,869
| -1% | -$184K |
|
|
WBA
228
DELISTED
Walgreens Boots Alliance
WBA
| $12.4M | 0.1% |
145,701
-5,256
| -3% | -$448K |
|
229
Costco
COST
$431B
| $12.4M | 0.1% |
76,801
-177
| -0.2% | -$28.6K |
|
230
Bristol-Myers Squibb
BMY
$95.1B
| $12.3M | 0.1% |
178,938
-5,494
| -3% | -$378K |
|
231
AbbVie
ABBV
$371B
| $12.3M | 0.1% |
207,603
-15,535
| -7% | -$920K |
|
232
Pacira BioSciences
PCRX
$1.2B
| $12.2M | 0.1% |
159,210
+25,708
| +19% | +$1.97M |
|
233
G-III Apparel Group
GIII
$1.17B
| $12M | 0.1% |
271,886
+1,884
| +0.7% | +$83.4K |
|
234
Axos Financial
AX
$5.21B
| $12M | 0.1% |
571,054
+9,290
| +2% | +$196K |
|
235
Federal Realty Investment Trust
FRT
$8.78B
| $11.9M | 0.1% |
81,692
+72,946
| +834% | +$10.7M |
|
236
McKesson
MCK
$86.7B
| $11.9M | 0.1% |
60,530
-1,648
| -3% | -$325K |
|
237
Hubbell
HUBB
$23.2B
| $11.8M | 0.1% |
+117,125
| New | +$11.8M |
|
238
Universal Display
OLED
$6.91B
| $11.7M | 0.09% |
+215,342
| New | +$11.7M |
|
|
NTUS
239
DELISTED
Natus Medical Inc
NTUS
| $11.7M | 0.09% |
243,025
+3,917
| +2% | +$188K |
|
240
Encompass Health
EHC
$12.7B
| $11.3M | 0.09% |
406,627
+9,829
| +2% | +$272K |
|
241
Empire State Realty Trust
ESRT
$1.32B
| $11.1M | 0.09% |
+617,108
| New | +$11.1M |
|
|
CHUY
242
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $11.1M | 0.09% |
355,199
+5,710
| +2% | +$179K |
|
|
EPAY
243
DELISTED
Bottomline Technologies Inc
EPAY
| $11.1M | 0.09% |
374,063
+5,933
| +2% | +$176K |
|
244
Protolabs
PRLB
$1.2B
| $11.1M | 0.09% |
174,574
+2,770
| +2% | +$176K |
|
|
ABCO
245
DELISTED
Advisory Board Co/The
ABCO
| $10.9M | 0.09% |
220,358
+3,502
| +2% | +$174K |
|
246
Donaldson
DCI
$9.47B
| $10.9M | 0.09% |
381,119
+2,627
| +0.7% | +$75.3K |
|
247
Trimble
TRMB
$19.3B
| $10.9M | 0.09% |
508,847
+11,174
| +2% | +$240K |
|
|
HPP
248
Hudson Pacific Properties
HPP
$1.15B
| $10.9M | 0.09% |
387,560
+214,223
| +124% | +$6.03M |
|
249
Lowe's Companies
LOW
$153B
| $10.8M | 0.09% |
142,449
+5,482
| +4% | +$417K |
|
250
IPG Photonics
IPGP
$3.5B
| $10.8M | 0.09% |
121,024
+2,888
| +2% | +$257K |
|